Skip to content

Drug interactions

Glofitamab + Valproic acid

Severity: Minor

Glofitamab and Valproic acid: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Glofitamab causes cytokine release that can transiently suppress CYP enzyme activity. Valproate depends only partly on CYP metabolism, so a significant effect on its exposure is unlikely.

What this interaction means in plain words

Glofitamab and Valproic acid have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Glofitamab belongs to Oncology; Valproic acid belongs to Central Nervous System.

Evidence level: Low

Why it happens

Cytokine-mediated suppression of CYP enzymes during cytokine release; limited relevance to valproate.

What to do

No routine adjustment is needed. Check valproate levels or watch for toxicity if cytokine release syndrome is severe.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glofitamab and Valproic acid, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glofitamab with Valproic acid?

MediHelp rates the interaction as minor. Glofitamab and Valproic acid have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Glofitamab causes cytokine release that can transiently suppress CYP enzyme activity. Valproate depends only partly on CYP metabolism, so a significant effect on its exposure is unlikely.

How serious is the interaction between Glofitamab and Valproic acid?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed. Check valproate levels or watch for toxicity if cytokine release syndrome is severe.

What other medicines interact with Valproic acid?

MediHelp also lists interactions of Valproic acid with, for example, Ertapenem, Imipenem / cilastatin / relebactam, Imipenem / cilastatin. The full list is on the Valproic acid page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in